Recruiting

Curettage with Cymetra

Sponsor:

Matino, James, M.D.

Code:

NCT00493493

Conditions

Pilonidal Sinus

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

surgery (Pore Excision, Curettage, and Injection of Cymetra)

Study Details

Brief summary:

Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.

Conditions

Pilonidal Sinus

Study ID

NCT00493493

Start date

Jan, 2007

Status verified date

Jun, 2007

Completion date

Jun, 2008

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any patient with pilonidal diseas

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

surgery (Pore Excision, Curettage, and Injection of Cymetra)

Primary outcome measure

  • wound failure, time lost from work or school, analgesic requirements, recurrence rates [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

James J Matino, MD

860-249-8595jimanderin@yahoo.com

Locations

St Francis Hospital

Recruiting

Hartford, Connecticut, United States, 06105

More Information

Sponsor

Matino, James, M.D.

Last update posted

Jun 28, 2007

Last verified

Jun, 2007

Keywords

  • Cymetra

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Matino, James, M.D. on 2007-06-28.